2024 asa guidance glp-1 receptor agonists perioperative 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP GLP-1 agonists and anesthesia risk:

Marks, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Impurities in synthetic peptides can confound experimental results, making third-party Certificate of Analysis (CoA) documentation a prerequisite for reliable research use

The core math The formula is the same for every peptide: Concentration (mg/mL) = Peptide amount (mg) / Bacteriostatic water added (mL) On a U-100 insulin syringe, 100 units = 1 mL

In the present review, we summarized the metabolic networks involving the amino acid cysteine in cancer and ferroptosis and we focused on describing the recently discovered glutathione-independent pathway, a potential player in cancer ferroptosis resistance